Nivolumab vs Ranitidine
Nivolumab vs Ranitidine: Overview
This comparison examines the pharmacological differences between Nivolumab and Ranitidine.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Ranitidine: Competitive H2 receptor antagonist.
Pharmacokinetics
Half-life: Nivolumab β 27 days; Ranitidine β 2-3 hours.
Chemical Properties
Molecular Formula: Ranitidine β C13H22N4O3S.
Molecular Weight: Ranitidine β 314.4050 g/mol.
Type: Nivolumab β Antibody; Ranitidine β Small molecule.